Publications

  1. Irazabal MV, Eirin A, Lieske J, Beck LH, Sethi S, Borland TM, Dillon JJ, Nachman PH, Nasr SH, Cornell LD, Leung N, Cattran DC, Fervenza FC. Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study. Nephrol Dial Transplant. 2013 Jan; 28(1):137-46. Epub 2012 Sep 17. 2271457
    View PubMed
  2. Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, Dasilva JR, Astor BC, Yevzlin AS, Humes HD. The Effect of the Selective Cytopheretic Device on Acute Kidney Injury Outcomes in the Intensive Care Unit: A Multicenter Pilot Study. Semin Dial. 2012 Oct 29. [Epub ahead of print] 2280771
    View PubMed
  3. Dillon JJ, Hladunewich M, Haley WE, Reich HN, Cattran DC, Fervenza FC. Rituximab therapy for Type I membranoproliferative glomerulonephritis. Clin Nephrol. 2012 Apr; 77(4):290-5. 2235367
    View PubMed
  4. Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, McCarthy JT, Nath KA. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1996-2002. Epub 2011 Jul 07. 2182138
    View PubMed
  5. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC, Mayo Nephrology Collaborative Group. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol. 2010 Dec; 5(12):2188-98. Epub 2010 Aug 12. 2129855
    View PubMed
  6. Lorenz EC, Vrtiska TJ, Lieske JC, Dillon JJ, Stegall MD, Li X, Bergstralh EJ, Rule AD. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol. 2010 Mar; 5(3):431-8. Epub 2010 Jan 14. 1985708
    View PubMed
  7. Lieske JC, Regnier C, Dillon JJ. Use of sevelamer hydrochloride as an oxalate binder. J Urol. 2008 Apr; 179(4):1407-10. Epub 2008 Mar 04. 1867613
    View PubMed
  8. Boseman P, Lewin M, Dillon J, Sethi S. Marfan syndrome, MPGN, and bacterial endocarditis. Am J Kidney Dis. 2008 Apr; 51(4):697-701. Epub 2008 Mar 03. 1885329
    View PubMed
  9. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int. 2008 Jan; 73(1):117-25. Epub 2007 Oct 17. 1861337
    View PubMed
  10. Dillon JJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol. 2004 May; 24(3):218-24. 1649142
    View PubMed
  11. Hartman AR, Fleming GF, Dillon JJ. Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer. Clin Breast Cancer. 2001 Jul; 2(2):138-43; discussion 144. 1431426
    View PubMed
  12. Dillon JJ. Nephrotoxicity from nonsteroidal anti-inflammatory drugs. MDVista Journalof Medicine Sept. 2000. 1266755
  13. Dillon JJ, IgA Nephropathy. IgA Nephropathy. . MDVista Journal of Medicine. 2000 Dec. 1266758
  14. Arnow PM, Garcia-Houchins S, Neagle MB, Bova JL, Dillon JJ, Chou T. An outbreak of bloodstream infections arising from hemodialysis equipment. J Infect Dis. 1998 Sep; 178(3):783-91. 1431359
    View PubMed
  15. Hartman AR, Williams SF, Dillon JJ. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis. Bone Marrow Transplant. 1998 Sep; 22(5):439-43. 1431360
    View PubMed
  16. Newell KA, Millis JM, Bruce DS, Woodle ES, Cronin DC, Loss G, Grewal H, Alonso EM, Dillon JJ, Whitington PF, Thistlethwaite JR Jr. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8. 1431358
    View PubMed
  17. Dillon JJ. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability. J Am Soc Nephrol. 1997 Nov; 8(11):1739-44. 1431333
    View PubMed
  18. Dillon JJ, Sedmak DD, Cosio FG. Rapid-onset diabetic nephropathy in type II diabetes mellitus. Ren Fail. 1997 Nov; 19(6):819-22. 1431328
    View PubMed
  19. Hebert LA, Birmingham DJ, Mahan JD, Cosio FG, Dillon JJ, Sedmak DD, Shen XP, McAllister C. Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate. Am J Kidney Dis. 1997 Aug; 30(2):243-52. 1431330
    View PubMed
  20. Birmingham DJ, Shen XP, Hartman JA, Dillon JJ, Hebert LA. Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients. Kidney Int. 1996 Aug; 50(2):543-9. 1431311
    View PubMed
  21. Hebert LA, Dillon JJ, Middendorf DF, Lewis EJ, Peter JB. Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus. Am J Kidney Dis. 1995 Sep; 26(3):432-8. 1431290
    View PubMed
  22. Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int. 1995 Apr; 47(4):1136-41. 1431288
    View PubMed
  23. Hebert LA, Birmingham DJ, Shen XP, Brandt JT, Sedmak DD, Dillon JJ. Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus. Am J Kidney Dis. 1994 Jul; 24(1):25-32. 1431278
    View PubMed
  24. Hebert LA, Birmingham DJ, Dillon JJ, Cosio FG, Shen XP. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). J Am Soc Nephrol. 1994 Apr; 4(10):1786-91. 1431269
    View PubMed
  25. Hebert LA, Birmingham DJ, Mahan JD, Shen XP, McAllister C, Cosio FG, Dillon JJ. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis. Kidney Int. 1994 Feb; 45(2):493-9. 1431268
    View PubMed
  26. Dillon JJ. The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis. 1993 Dec; 22(6):798-802. 1431257
    View PubMed
  27. Dillon JJ, Grossman SH, Finn WF. Effect of oxypurinol on renal reperfusion injury in the rat. Ren Fail. 1993; 15(1):37-45. 1431256
    View PubMed
  28. McCormack AJ, Snipes RG, Dillon JJ, Yang JJ, Finn WF. Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity. Ren Fail. 1990; 12(4):241-8. 1431199
    View PubMed
  29. Dillon JJ, Finn WF. How can the high mortality of acute renal failure be reduced? Semin Dial. 1988; 1:133-5. 1431161